What is Sickle Cell Anemia

Sickle cell anemia is a chronic, inherited blood disorder characterized by the production of abnormal hemoglobin, which causes red blood cells to become rigid and crescent-shaped rather than flexible and round. These misshapen cells can block blood flow, leading to severe pain, organ damage, and an increased risk of infections. While it is a lifelong condition, advancements in medical care have significantly improved life expectancy and quality of life for those living with the disease.

What causes sickle cell anemia and how does it affect the body?

Sickle cell anemia is caused by a genetic mutation in the hemoglobin-beta gene. Normally, red blood cells are disc-shaped and move easily through blood vessels. In individuals with sickle cell anemia, the hemoglobin molecules clump together when oxygen levels are low, causing the cells to turn into a "sickle" or C-shape. Because these cells are stiff and sticky, they get stuck in small blood vessels, preventing oxygen from reaching tissues and organs. This process, known as vaso-occlusion, is the primary driver of the pain crises, organ damage (particularly in the spleen, kidneys, and lungs), and chronic anemia associated with the condition.

Who is typically affected by sickle cell anemia?

Sickle cell anemia is a global health concern, though it most frequently affects individuals of African, Mediterranean, Middle Eastern, and Indian descent. It is an autosomal recessive disorder, meaning a child must inherit two copies of the mutated gene—one from each parent—to develop the disease. The symptoms typically emerge in early childhood, often within the first year of life. While the prevalence varies significantly by region, the World Health Organization estimates that hundreds of thousands of children are born with sickle cell disorders annually worldwide.

What are the different types of sickle cell disease?

While sickle cell anemia (specifically the HbSS genotype) is the most severe and common form, "sickle cell disease" is an umbrella term that includes several variations. These subtypes are defined by the specific genetic mutations present:

• HbSS: The most common and severe form, where two copies of the sickle hemoglobin gene are inherited.


• HbSC: Often results in milder anemia than HbSS but carries a higher risk of eye complications and blood clots.


• HbS beta-thalassemia: Occurs when a person inherits one sickle gene and one gene for beta-thalassemia, leading to varying degrees of severity.


• Sickle Cell Trait (HbAS): Individuals possess only one sickle gene and usually do not experience symptoms, though they can pass the gene to their children.

How does sickle cell anemia differ from other blood disorders?

Unlike iron-deficiency anemia, which is caused by a lack of nutrients, sickle cell anemia is a structural issue with the hemoglobin protein itself. It is distinct from other hemoglobinopathies because of the unique "sickling" mechanism that leads to acute vaso-occlusive crises. Within the DiseaseMaps.org community, 133 people with sickle cell anemia have shared their experiences, highlighting the importance of specialized hematological care and pain management strategies tailored specifically to the unique pathophysiology of this condition.

Next steps

• Consult a hematologist specializing in hemoglobinopathies to establish a personalized care plan.


• Join a patient support community, such as the 133 members on DiseaseMaps.org, to share experiences and coping strategies.


• Schedule regular screenings for common complications like retinopathy, splenic sequestration, and stroke risk.


• Discuss genetic counseling with a certified professional if you are planning to start a family.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified physician with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Sickle Cell Disease


• Orphanet: Sickle Cell Disease (ORPHA:232)


• OMIM (Online Mendelian Inheritance in Man): Hemoglobin—Beta Locus; HBB


• Sickle Cell Disease Association of America (SCDAA)